Literature DB >> 10652619

Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.

K Kawakami1, K Omura, E Kanehira, Y Watanabe.   

Abstract

BACKGROUND: Thymidylate synthase (TS) is a target enzyme of 5-fluorouracil (5-FU), and the TS gene has a polymorphic tandem repeated sequence in the 5'-untranslated region. We investigated the polymorphism on the repeat length of the TS gene and its relation to the number of 5-fluoro-dUMP (FdUMP) binding sites in human gastrointestinal cancers.
MATERIALS AND METHODS: Seventy adenocarcinoma samples were used. Twenty-one patients received UFT and 49 patients received no treatment before surgery. Tandem repeat length of TS gene was determined by PCR amplification of genomic DNA. The number of FdUMP binding sites were measured by 3H-FdUMP binding assay.
RESULTS: Double- (2R) and triple-repeated (3R) sequences of the TS gene were found in the cancer tissues. Three genotypes of TS were found: 2R/2R (n = 3), 2R/3R (n = 16) and 3R/3R (n = 51). The free TS level for the 3R/3R genotype was significantly higher than for the 2R/3R genotype in UFT (+) group. Similar genotype-dependent difference of TS level was observed in UFT (-) group.
CONCLUSIONS: Our results suggest the link between TS genotype and TS protein expression. This link might offer an advantage for selection of patients to receive 5-FU-based chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10652619

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  50 in total

1.  TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients.

Authors:  A Fariña-Sarasqueta; M J E M Gosens; E Moerland; I van Lijnschoten; V E P P Lemmens; G D Slooter; H J T Rutten; Adriaan J C van den Brule
Journal:  Cell Oncol (Dordr)       Date:  2011-06-01       Impact factor: 6.730

Review 2.  Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.

Authors:  Norman H Lee
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

3.  Looking for the right drug for the right patient: a tale of old drugs and new pathways.

Authors:  Emilio Alba; Nuria Ribelles
Journal:  Clin Transl Oncol       Date:  2005-10       Impact factor: 3.405

4.  Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population.

Authors:  M Acuña; L Eaton; L Cifuentes; D Massardo
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

5.  EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer.

Authors:  A Sebio; J Salazar; D Páez; A Berenguer-Llergo; E Del Río; M Tobeña; M Martín-Richard; I Sullivan; E Targarona; J Balart; M Baiget; A Barnadas
Journal:  Pharmacogenomics J       Date:  2014-07-15       Impact factor: 3.550

Review 6.  Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.

Authors:  Eva Bandrés; Ruth Zárate; Natalia Ramirez; Ana Abajo; Nerea Bitarte; Jesus Garíia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Reduced folate carrier-1 G80a gene polymorphism is associated with neuroblastoma's development.

Authors:  Dyego O de Miranda; Jemima E X S Barros; Maria Madalena S Vieira; Elker L S Lima; Vera L L Moraes; Helker A da Silva; Helder L B O Garcia; Cássia A Lima; Adriana V Gomes; Neide Santos; Maria T C Muniz
Journal:  Mol Biol Rep       Date:  2014-04-27       Impact factor: 2.316

8.  Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Authors:  Aurea Lima; Vítor Seabra; Sandra Martins; Ana Coelho; António Araújo; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2014-02-20       Impact factor: 2.316

9.  Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics.

Authors:  Hanna K Sanoff; Howard L McLeod
Journal:  Semin Colon Rectal Surg       Date:  2008-12

10.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.